Primary outcome analysis of the phase 3 SONIA trial (BOOG 2017-03) on selecting the optimal position of cyclin-dependent kinases 4 and 6 (CDK4/6) inhibitors for patients with hormone receptor-positive (HR+), HER2-negative (HER2-) advanced breast cancer (ABC).

被引：58

作者：

Sonke, Gabe S. ^{[1
]}

Van Ommen-Nijhof, Annemiek ^{[1
]}

Wortelboer, Noor ^{[2
]}

van der Noort, Vincent ^{[1
]}

Swinkels, Astrid C. P. ^{[3
]}

Blommestein, Hedwig M. ^{[4
]}

Beeker, Aart ^{[5
]}

Beelen, Karin ^{[6
]}

Hamming, Lisanne C. ^{[7
]}

Heijns, Joan B. ^{[8
]}

Honkoop, Aafke H. ^{[9
]}

De Jong, Paul C. ^{[10
]}

Van Rossum-Schornagel, Quirine C. ^{[11
]}

van Schaik-van de Mheen, Christa ^{[12
]}

Tol, Jolien ^{[13
]}

Tromp-Van Driel, Cathrien ^{[14
]}

Vrijaldenhoven, Suzan ^{[15
]}

Van Leeuwen-Stok, A. Elise ^{[16
]}

Konings, Inge ^{[17
]}

Jager, Agnes ^{[18
]}

机构：

[1] Netherlands Canc Inst, Amsterdam, Netherlands

[2] Erasmus MC Canc Inst, Rotterdam, Netherlands

[3] Netherlands Comprehens Canc Org IKNL, Nijmegen, Netherlands

[4] Erasmus Sch Hlth Policy Management, Rotterdam, Netherlands

[5] Spaarne Gasthuis, Hoofddorp, Netherlands

[6] Rijnstate Hosp, Arnhem, Netherlands

[7] Med Ctr Leeuwarden, Leeuwarden, Netherlands

[8] Amphia Hosp, Breda, Netherlands

[9] Isala, Zwolle, Netherlands

[10] St Antonius Hosp, Nieuwegein, Netherlands

[11] Franciscus Gasthuis Vlietland, Schiedam, Netherlands

[12] Meander Med Ctr, Amersfoort, Netherlands

[13] Jeroen Bosch Hosp, Shertogenbosch, Netherlands

[14] Gelre Hosp, Apeldoorn, Netherlands

[15] Northwest Clin, Alkmaar, Netherlands

[16] Dutch Breast Canc Res Grp BOOG, Utrecht, Netherlands

[17] Vrije Univ Amsterdam, Amsterdam Univ Med Ctr, Amsterdam, Netherlands

[18] Erasmus MC Canc Inst, Rotterdam, Netherlands

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 17_SUPPL期

关键词：

D O I：

10.1200/JCO.2023.41.17_suppl.LBA1000

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：LBA1000 / LBA1000

页数：1